CAS: 2230757-47-6
Acalabrutinib Impurity 1-d4
CAS:2230757-47-6
Formula:
C26H19D4N7O3
Color and Shape:
Yellow Solid
Molecular weight:
485.54
Ref: 4Z-A-001011
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Acalabrutinib Impurity 1
CAS:2230757-47-6
Formula:
C26H23N7O3
Color and Shape:
Yellow Solid
Molecular weight:
481.52
Ref: 4Z-A-001003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Des-1-(1-pyrrolidinyl)-2-butyn-1-one N-(4-oxobutyl)but-2-ynamide Acalabrutinib-d3
Controlled ProductCAS:2230757-47-6
Formula:
C26D3H20N7O3
Color and Shape:
Neat
Molecular weight:
484.524
Ref: TR-A621882
50mg | 22,540.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
4-[8-Amino-3-[1-oxo-4-[(1-oxo-2-butyn-1-yl)amino]butyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-benzamide
Controlled ProductCAS:2230757-47-6
Formula:
C26H23N7O3
Color and Shape:
Neat
Molecular weight:
481.506
Ref: TR-A621885
100mg | 13,318.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
ACP-5862
CAS:2230757-47-6
ACP-5862, active metabolite of Acalabrutinib, is a BTK inhibitor with an IC50 of 5.0 nM.
Formula:
C26H23N7O3
Color and Shape:
Solid
Molecular weight:
481.51
Ref: TM-T10240
25mg | 1,410.00 € | ||
50mg | 1,854.00 € | ||
100mg | 2,340.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
Des-1-(1-pyrrolidinyl)-2-butyn-1-one N-(4-oxobutyl)but-2-ynamide Acalabrutinib-d3
CAS:2230757-47-6
Please enquire for more information about Des-1-(1-pyrrolidinyl)-2-butyn-1-one N-(4-oxobutyl)but-2-ynamide Acalabrutinib-d3 including the price, delivery time and …
Formula:
C26H20D3N7O3
Purity:
Min. 95%
Molecular weight:
484.52 g/mol
Ref: 3D-FPD75747
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |